Literature DB >> 27534639

Statistical design considerations applicable to clinical trials of iodine supplementation in pregnant women who may be mildly iodine deficient.

James F Troendle1.   

Abstract

No large, randomized, placebo-controlled trial of iodine supplementation in pregnant women in a region of mild or moderate iodine deficiency has been completed in which a primary outcome measure was an assessment of the neurobehavioral development of the offspring at age ≥2 y. In this article, I discuss considerations for the design of such a trial in a region of mild iodine deficiency, with a focus on statistical methods and approaches. Exposure and design issues include the ethics of using a placebo, the potential for overexposure to iodine, and the possibility of community randomization. The main scientific goal of the trial is important in determining the follow-up period. If the goal is to determine whether iodine supplementation during pregnancy improves neurobehavioral development in the offspring, then follow-up should continue until a reasonably reliable assessment can be conducted, which might be at age ≥2 y. Once the timing of assessment is decided, the impact of potential loss to follow-up should be considered so that appropriate statistical methods can be incorporated into the design. The minimum sample size can be calculated by using a sample size formula that incorporates noncompliance and assumes that a certain proportion of study participants do not have any outcome observed. To have sufficient power to detect a reasonably modest difference in neurobehavioral development scores using an assessment tool with an SD of 15, a large number of participants (>500/group) is required. The minimum adequate number of participants may be even larger (>1300/group) depending on the magnitude of the difference in outcome between the supplementation and placebo groups, the estimated proportion of the iodine-supplementation group that fails to take the supplement, and the estimated proportion of pregnancies that do not produce outcome measurements.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  clinical trials; iodine supplementation; outcomes measurement; pregnancy; statistical methods

Mesh:

Substances:

Year:  2016        PMID: 27534639      PMCID: PMC5004499          DOI: 10.3945/ajcn.115.110403

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  14 in total

1.  Combining mortality and longitudinal measures in clinical trials.

Authors:  D M Finkelstein; D A Schoenfeld
Journal:  Stat Med       Date:  1999-06-15       Impact factor: 2.373

Review 2.  Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials.

Authors:  Shao J Zhou; Amanda J Anderson; Robert A Gibson; Maria Makrides
Journal:  Am J Clin Nutr       Date:  2013-09-11       Impact factor: 7.045

3.  Ten repeat collections for urinary iodine from spot samples or 24-hour samples are needed to reliably estimate individual iodine status in women.

Authors:  Franziska König; Maria Andersson; Karin Hotz; Isabelle Aeberli; Michael B Zimmermann
Journal:  J Nutr       Date:  2011-09-14       Impact factor: 4.798

Review 4.  Iodine-induced thyroid dysfunction.

Authors:  Angela M Leung; Lewis E Braverman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-10       Impact factor: 3.243

Review 5.  Assessing infant cognitive development after prenatal iodine supplementation.

Authors:  Martha Ann Bell; Alleyne P Ross; Gay Goodman
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

6.  Day-to-day and within-day variation in urinary iodine excretion.

Authors:  L B Rasmussen; L Ovesen; E Christiansen
Journal:  Eur J Clin Nutr       Date:  1999-05       Impact factor: 4.016

7.  Suggested use of sensitive measures of memory to detect functional effects of maternal iodine supplementation on hippocampal development.

Authors:  Patricia J Bauer; Jessica A Dugan
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

8.  Iodine status of the U.S. population, National Health and Nutrition Examination Survey, 2005–2006 and 2007–2008.

Authors:  Kathleen L Caldwell; Amir Makhmudov; Elizabeth Ely; Robert L Jones; Richard Y Wang
Journal:  Thyroid       Date:  2011-04       Impact factor: 6.568

9.  Coping with missing data in clinical trials: a model-based approach applied to asthma trials.

Authors:  James Carpenter; Stuart Pocock; Carl Johan Lamm
Journal:  Stat Med       Date:  2002-04-30       Impact factor: 2.373

Review 10.  Appraisal of neurobehavioral methods in environmental health research: the developing brain as a target for neurotoxic chemicals.

Authors:  Gerhard Winneke
Journal:  Int J Hyg Environ Health       Date:  2007-09-14       Impact factor: 5.840

View more
  3 in total

1.  Assessing iodine intake, iodine status, and the effects of maternal iodine supplementation: introduction to articles arising from 3 workshops held by the NIH Office of Dietary Supplements.

Authors:  Abby G Ershow; Gay Goodman; Paul M Coates; Christine A Swanson
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

Review 2.  Research needs for assessing iodine intake, iodine status, and the effects of maternal iodine supplementation.

Authors:  Abby G Ershow; Gay Goodman; Paul M Coates; Christine A Swanson
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

3.  Role of iodine-containing multivitamins during pregnancy for children's brain function: protocol of an ongoing randomised controlled trial: the SWIDDICH study.

Authors:  Sofia Manousou; Birgitta Johansson; Anna Chmielewska; Janna Eriksson; Kerstin Gutefeldt; Carl-Johan Tornhage; Robert Eggertsen; Helge Malmgren; Lena Hulthen; Magnus Domellöf; Helena Nystrom Filipsson
Journal:  BMJ Open       Date:  2018-04-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.